Sector
PharmaceuticalsOpen
₹104.24Prev. Close
₹99.29Turnover(Lac.)
₹219.09Day's High
₹104.25Day's Low
₹10252 Week's High
₹11152 Week's Low
₹49.06Book Value
₹24.98Face Value
₹10Mkt Cap (₹ Cr.)
769.05P/E
91.49EPS
1.15Divi. Yield
019 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
5 Sep 2024
12:00 AM
AGM
Announcement Date: 05 Sep, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 73.77 | 73.77 | 73.77 | 44.27 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 129.78 | 122.22 | 110.74 | 105.28 |
Net Worth | 203.55 | 195.99 | 184.51 | 149.55 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Revenue | 16.46 | 20.34 | 31.04 | 30.03 |
yoy growth (%) | -19.06 | -34.47 | 3.35 | -43.71 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | -8.57 | -7.75 | -15.81 | -14.62 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Profit before tax | 1.38 | 0.51 | 0.62 | 0.89 |
Depreciation | -3.43 | -3.44 | -0.66 | -0.63 |
Tax paid | 0 | 0.03 | 0.51 | -0.47 |
Working capital | -3.05 | -121.58 | 13.22 | -29.74 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -19.06 | -34.47 | 3.35 | -43.71 |
Op profit growth | -39.31 | -125.46 | -244.24 | -45.16 |
EBIT growth | -1.64 | 41.81 | -10.36 | 0.41 |
Net profit growth | 149.2 | -51.05 | 170.09 | -31.49 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 0 | 0 | 1.97 | 52.4 | 59.4 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 0 | 0 | 1.97 | 52.4 | 59.4 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 41.56 | 37.4 | 42.81 | 30.12 | 6.86 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director & CEO
Sunil Kumar Kalidindi
Non Executive Director
Leona Ambuja
Independent Non Exe. Director
Kalyan Vijay Sivalenka
Non-Exec & Non-Independent Dir
Suryanarayana Raju Nandyala
Non Executive Director
Krishna Yeachuri
Independent Director
Uma Garimella
85 Kutchery Road,
Mylapore,
Tamil Nadu - 600004
Tel: 91-44-24616768
Website: http://www.megasoft.com
Email: [email protected]; srivalli.manda@Megasoft.
Subramanian Building,
1ST Floor No 1, Club House Road,
Chennai - 600002
Tel: 91-44-28462700
Website: www.cameoindia.com
Email: [email protected]
Summary
Megasoft Limited is a transnational intellectual property-driven, product-based technology company, which incorporated on 29th June 1999 and focused its expertise on the telecom sector. The Company pr...
Read More
Reports by Megasoft Ltd
What is the Megasoft Ltd share price today?
What is the Market Cap of Megasoft Ltd?
What is the PE and PB ratio of Megasoft Ltd?
What is the 52 Week High and Low of Megasoft Ltd?
What is the CAGR of Megasoft Ltd?
What is the shareholding pattern of Megasoft Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.